AMERISAFEAMSF
AMSF logo
Fair Value
US$36.67
Share price22 Jun
US$31.1515.0% undervalued intrinsic discount
Loading
1Y-29.20%
7D-4.94%

AMSF: Financial Tailwinds And Reduced Catastrophe Losses Will Support Share Performance

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
24 Sep 24
Updated
22 Jun 26
Views
63
Not Invested

Last Update 22 Jun 26

Fair value Decreased 5.17%

AMSF: Underwriting Discipline And Rebased P/E Are Expected To Drive Repricing

The updated analyst price target for AMERISAFE has been reduced by about $2, as analysts factor in adjustments to fair value estimates, discount rates, revenue growth expectations, profit margins, and future P/E assumptions.

Analyst Commentary

Recent Street research on AMERISAFE highlights both optimism and caution as analysts recalibrate their assumptions around valuation, execution, and growth. The reduced price targets reflect updated models rather than a single issue, with attention on how AMERISAFE can balance profitability, growth initiatives, and capital discipline.

Bullish Takeaways

  • Bullish analysts view the revised price targets as bringing AMERISAFE closer to their updated fair value estimates, which they see as better aligned with the company’s current fundamentals.
  • Some see room for upside if AMERISAFE can execute consistently on underwriting discipline and expense control, which could support more resilient profit margins over time.
  • Optimistic views point to the potential for AMERISAFE to benefit from any improvements in pricing or mix within its book, which could support earnings relative to current P/E assumptions.
  • Bullish analysts highlight that the lower targets may create a more conservative starting point, which they believe reduces the risk of future valuation disappointments if execution is steady.

Bearish Takeaways

  • Bearish analysts focus on the reduced price targets as a signal that prior expectations for AMERISAFE’s revenue growth and profitability may have been too high, leading to more cautious fair value estimates.
  • There is concern that if margins do not track in line with updated forecasts, the company’s earnings could fall short of current P/E assumptions, which could limit the scope for multiple expansion.
  • Some cautious views emphasize that even with adjusted discount rates and growth inputs, AMERISAFE’s valuation leaves limited room for execution hiccups on claims, pricing, or costs.
  • Bearish analysts also point to the possibility that further model revisions could be required if AMERISAFE’s operating trends or external conditions differ from the updated scenarios used in the latest target cuts.

What’s in the News for AMERISAFE

  • At the 2026 annual meeting of shareholders held on June 10, 2026, AMERISAFE approved an amendment to the Company’s Certificate of Formation to make technical amendments to its governing documents. (Source: Key Developments)
  • Ahead of the same 2026 annual meeting, AMERISAFE sought shareholder approval for an amendment to the Certificate of Formation to provide for officer exculpation and to make technical and conforming changes. (Source: Key Developments)
  • From January 1, 2026 to March 31, 2026, AMERISAFE repurchased 119,959 shares, representing 0.64% of its stock, for US$4.03 million. This completed the repurchase of 320,396 shares, or 1.69%, for US$12.11 million under the buyback announced on July 24, 2025. (Source: Key Developments)
  • AMERISAFE announced that Guillermo A. Ramos, age 56, will become the Company’s Chief Financial Officer effective May 7, 2026, bringing prior experience from Hiscox US and Equifax. (Source: Key Developments)

Valuation Changes for AMERISAFE

  • Fair Value: revised from $38.67 to $36.67, a reduction of about $2.00 that brings the modeled fair value closer to the updated assumptions.
  • Discount Rate: increased slightly from 6.98% to 7.11%, indicating a modestly higher required return in the current valuation framework.
  • Revenue Growth: adjusted from 4.09% to 4.45%, reflecting a small uplift in AMERISAFE’s modeled top line growth rate.
  • Net Profit Margin: reduced from 10.03% to 8.20%, pointing to a more conservative view on AMERISAFE’s future profitability in the updated forecasts.
  • Future P/E: moved from 23.75x to 25.24x, implying a slightly higher valuation multiple being used in the refreshed model.
1 viewusers have viewed this narrative update

Key Takeaways

  • Strong growth in policies and voluntary premiums, supported by agent partnerships and technology investment, is driving revenue expansion and margin improvement.
  • High retention, disciplined risk selection, and prudent capital management are supporting long-term earnings stability and attractive shareholder returns.
  • Ongoing pricing pressure, rising costs, and slower policy growth threaten AMERISAFE's premium revenue, profitability, and long-term earnings potential.

Catalysts

About AMERISAFE
    An insurance holding company, underwrites workers’ compensation insurance in the United States.
What are the underlying business or industry changes driving this perspective?
  • Robust policy count growth (3.4% in the quarter, 5.8% year-to-date) and voluntary premium growth (12.8% in the quarter) indicate AMERISAFE is effectively increasing its addressable market by leveraging operational efficiency and deep agent partnerships, which positions the company to drive top-line revenue expansion.
  • The ongoing investment in technology, agent effectiveness, and process scalability supports more efficient underwriting and claims management, which should help lower expense ratios and sustain or improve net margins over the long-term.
  • Strong renewal retention (93.8%) and disciplined risk selection in high-hazard sectors are likely to sustain attractive combined ratios and above-industry underwriting profit margins, bolstering long-term earnings stability.
  • The company's prudent capital management-demonstrated through consistent share repurchases and dividends-enhances shareholder returns and supports book value per share growth, positively impacting valuation multiples.
  • Industry-wide increases in medical severity and regulatory shifts could harden the workers' comp market, benefitting specialized players like AMERISAFE who can adapt quickly, thereby driving future premium growth and supporting net income resilience.
AMERISAFE Earnings and Revenue Growth

AMERISAFE Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming AMERISAFE's revenue will grow by 4.4% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 14.3% today to 8.2% in 3 years time.
  • Analysts expect earnings to reach $30.3 million (and earnings per share of $1.58) by about June 2029, down from $46.3 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 26.5x on those 2029 earnings, up from 12.6x today. This future PE is greater than the current PE for the US Insurance industry at 11.3x.
  • Analysts expect the number of shares outstanding to decline by 1.51% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.11%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The long-term decline in approved workers' compensation loss costs (down mid-single digits year-after-year) signals ongoing pricing pressure in the industry; if this persists, it may continue to compress AMERISAFE's premium rates and constrain top-line revenue growth, especially as wage inflation no longer outpaces rate declines.
  • The company's policy count growth has been achieved with a significant reduction in agent count (from 2,200 to ~1,600 in under two years), which may indicate challenges in sustaining new business momentum going forward, potentially slowing future premium and revenue growth.
  • Rising medical severity costs (up 6% industry-wide according to NCCI) are placing upward pressure on the company's core 71% accident year loss ratio target, which management acknowledges may face additional strain if these trends continue, risking future net margin and underwriting profitability.
  • Audit premium, a material contributor to net premiums earned, has declined meaningfully compared to prior years; as this source of "immediate" premium continues to moderate, it could further weigh on premium revenue and the company's ability to offset soft market conditions.
  • Expense ratios have risen (31.3% in the quarter vs. 29.8% prior year), with continued investment in growth initiatives and higher insurance-based assessments; if top-line growth stalls or operational efficiency gains do not materialize, persistently elevated expense ratios could erode earnings and limit long-term profit expansion.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $36.67 for AMERISAFE based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $45.0, and the most bearish reporting a price target of just $31.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $370.1 million, earnings will come to $30.3 million, and it would be trading on a PE ratio of 26.5x, assuming you use a discount rate of 7.1%.
  • Given the current share price of $31.32, the analyst price target of $36.67 is 14.6% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on AMERISAFE?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$31
FV
0.5% overvalued intrinsic discount
4.54%
Revenue growth p.a.
11
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$45
FV
30.8% undervalued intrinsic discount
5.20%
Revenue growth p.a.
18
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Fair Value vs Share Price

US$36.67
vs US$31.1515.0% undervalued intrinsic discount
PastFuture0409m2015201820212024202620272029Revenue US$370.1mEarnings US$30.3m
4.4%
Revenue growth
8.2%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on AMERISAFE

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet average dividend payer.

Market capUS$635.1m
PB2.3x
Estimated Growth2.3%
Dividend Yield8.5%
Full analysis

CEO & management

Gerry Frost
CEO
8.4yrs
CEO Tenure

An insurance holding company, underwrites workers’ compensation insurance in the United States.